Literature DB >> 8486697

RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc.

W G Kelly1, M E Dahmus, G W Hart.   

Abstract

The largest subunit of mammalian RNA polymerase II (RNAP II) contains at its carboxyl terminus an unusual domain consisting of 52 tandem repeats of the consensus sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser. This domain, designated the COOH-terminal domain (CTD), is essential for viability and is extensively phosphorylated during the transition from preinitiation complex assembly to elongation (1). Indeed, phosphorylation of the CTD may play an important regulatory role in this transition. We show here that the CTD is also modified by a novel form of protein glycosylation, O-GlcNAc. This modification has been found on numerous transcription factors and other nuclear and cytosolic proteins (2). Glycopeptides obtained by proteolytic digestion of the CTD were purified by reverse-phase high performance liquid chromatography and sequenced. Results from such experiments suggest that glycosylation occurs at multiple sites throughout the CTD, similar to the phosphorylation of this domain. The carbohydrate, however, is not detectable on the phosphorylated form of the enzyme. This observation is consistent with the idea that phosphorylation and glycosylation are mutually exclusive modifications. The CTD of RNAP II, therefore, appears to exist in three distinct conformational states: unmodified, phosphorylated, and glycosylated. The differential modification of the CTD may play an important role in the regulated expression of genes transcribed by RNA polymerase II.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486697

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  126 in total

1.  Identification of GlcNAcylation sites of peptides and alpha-crystallin using Q-TOF mass spectrometry.

Authors:  R J Chalkley; A L Burlingame
Journal:  J Am Soc Mass Spectrom       Date:  2001-10       Impact factor: 3.109

Review 2.  RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function.

Authors:  Gregory Prelich
Journal:  Eukaryot Cell       Date:  2002-04

Review 3.  The RNA polymerase II CTD "orphan" residues: Emerging insights into the functions of Tyr-1, Thr-4, and Ser-7.

Authors:  Nathan M Yurko; James L Manley
Journal:  Transcription       Date:  2017-10-04

4.  O-linked beta-N-acetylglucosamine (O-GlcNAc) regulates stress-induced heat shock protein expression in a GSK-3beta-dependent manner.

Authors:  Zahra Kazemi; Hana Chang; Sarah Haserodt; Cathrine McKen; Natasha E Zachara
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 5.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

6.  Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.

Authors:  Nelly Khidekel; Scott B Ficarro; Eric C Peters; Linda C Hsieh-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

7.  New mammalian selenium-containing protein V: the search for protein partners.

Authors:  E G Varlamova; S V Novoselov; V I Novoselov; E E Fesenko
Journal:  Dokl Biochem Biophys       Date:  2012-01-06       Impact factor: 0.788

8.  Combined Antibody/Lectin Enrichment Identifies Extensive Changes in the O-GlcNAc Sub-proteome upon Oxidative Stress.

Authors:  Albert Lee; Devin Miller; Roger Henry; Venkata D P Paruchuri; Robert N O'Meally; Tatiana Boronina; Robert N Cole; Natasha E Zachara
Journal:  J Proteome Res       Date:  2016-10-14       Impact factor: 4.466

9.  Up-regulation of O-GlcNAc transferase with glucose deprivation in HepG2 cells is mediated by decreased hexosamine pathway flux.

Authors:  Rodrick P Taylor; Taylor S Geisler; Jefferson H Chambers; Donald A McClain
Journal:  J Biol Chem       Date:  2008-12-10       Impact factor: 5.157

Review 10.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.